Qiagen N.V (QGEN) | Stock Overview & Key Data
Qiagen N.V Performance Comparison
Stock Range
Today's Range
Low: $47.63
High: $48.14
on August 8, 2025
52 Week Range
Low: $37.63
High: $51.88
on March 4, 2025
on July 25, 2025
All-Time High: $60.81 on July 17, 2000
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$10.8B
EPS
0.43
P/E Ratio (TTM)
116.12
Forward P/E
21.80
P/B Ratio
3.17
PEG Ratio
21.80
Div. Yield
N/A
ROE
2.67%
Beta
0.644
Debt to Equity
41.36
Financial Highlights
Profitability
Gross Margin
63.85%
Operating Margin
26.16%
Profit Margin
4.68%
Returns and Earnings
Return on Assets (TTM)
5.76%
Return on Equity (TTM)
2.67%
EBITDA
$470.4M
Net Income (TTM)
$93.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$9.27
Quarterly Revenue Growth (YoY)
5.40%
Quarterly Earnings Growth (YoY)
12.50%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Qiagen N.V QGEN | 10.81B Large-cap | -3.80% | 0.40% | 13.95% | 19.86% | 7.91% | 5.72% | -3.81% | -2.89% |
| Thermo Fisher TMO | 176.13B Large-cap | -0.50% | 8.11% | 12.16% | -16.67% | -11.84% | -22.72% | -23.62% | 11.35% |
| Danaher DHR | 139.75B Large-cap | 1.76% | -0.06% | 2.95% | -1.44% | -12.73% | -25.18% | -24.01% | 10.45% |
| Idexx Laboratories IDXX | 52.43B Large-cap | 22.88% | 22.13% | 34.30% | 41.55% | 60.95% | 36.29% | 66.00% | 73.45% |
| Agilent Technologies A | 32.30B Large-cap | 1.00% | -5.27% | 5.46% | -20.22% | -14.09% | -16.25% | -14.15% | 17.75% |
| Iqvia Holdings IQV | 30.42B Large-cap | -1.42% | 9.36% | 17.33% | -13.10% | -7.82% | -24.26% | -26.83% | 11.55% |
Ownership & Short Interest
Insider Ownership
1.61%
Institutional Ownership
86.99%
Shares Short
6M
Short Ratio
4.40
Short % of Shares Outstanding
4.32%
Average 10-Day Volume
1M
Average 90-Day Volume
1M
Qiagen N.V Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Qiagen N.V would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is QGEN's 52-week high and low?
- In the last 52 weeks, Qiagen N.V reached a high of $51.88 (on July 25, 2025) and a low of $37.63 (on March 4, 2025).
- What is the market cap and P/E ratio for QGEN?
- Curious about Qiagen N.V's size and valuation? Its market capitalization stands at 10.81B. When it comes to valuation, the P/E ratio (trailing twelve months) is 116.12, and the forward P/E (looking ahead) is 21.80.
- Does QGEN pay dividends? If so, what's the yield?
- As for dividends, Qiagen N.V isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Qiagen N.V's main competitors or similar companies to consider before investing?
When looking at Qiagen N.V, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO176.13B Healthcare Diagnostics & Research -22.72% -23.62% Danaher
DHR139.75B Healthcare Diagnostics & Research -25.18% -24.01% Idexx Laboratories
IDXX52.43B Healthcare Diagnostics & Research 36.29% 66.00% Agilent Technologies
A32.30B Healthcare Diagnostics & Research -16.25% -14.15% Iqvia Holdings
IQV30.42B Healthcare Diagnostics & Research -24.26% -26.83% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Qiagen N.V.? (e.g., ROE, Debt/Equity)
- To get a sense of Qiagen N.V's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 2.67%, the Debt to Equity ratio from the most recent quarter is 41.36, and its Gross Profit Margin stands at 63.85%.
- What is the recent revenue and earnings growth for QGEN?
- Looking at Qiagen N.V's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 5.40%, and quarterly earnings saw a YoY growth of 12.50%.
- How much of QGEN stock is held by insiders and institutions?
- Wondering who owns Qiagen N.V stock? Company insiders (like executives and directors) hold about 1.61% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 86.99%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.